Aprepitant
- Product NDC
- 68001-668
- 11-digit product format
- 680010668
- Labeler code
- 68001
- Product ID
- 68001-668_4e00638d-1cbc-f20f-e063-6294a90ac14c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Aprepitant
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- BluePoint Laboratories
- Application
- ANDA207777
- Marketing category
- ANDA
- Marketing start
- 2026-02-10
- Substance
- APREPITANT
- Active strength
- 125 mg/1
- Pharmacologic classes
- Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Aprepitant
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| APREPITANT | 125 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1NF15YR6UY |
| Rxcui | 403810, 403811, 644088, 754508 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68001-668-19 | Aprepitant | 1 in 1 CARTON | CAPSULE | 1 | | 2 |
| 68001-668-44 | Aprepitant | 6 in 1 BLISTER PACK | CAPSULE | 6 | | 2 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68001-668-19 | 68001066819 | 1 BLISTER PACK in 1 CARTON (68001-668-19) / 6 CAPSULE in 1 BLISTER PACK (68001-668-44) | 1 blister pack | 2026-02-10 | No | No | Current |
| 68001-668-44 | 68001066844 | 6 in 1 BLISTER PACK | | | | | Historical |